Literature DB >> 17008491

Genetic testing oversight.

Kathy L Hudson.   

Abstract

Mesh：

Year:  2006        PMID： 17008491     DOI： 10.1126/science.1134996

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  6 in total

1.  Molecular diagnostics. At the nexus of individualized medicine, health care delivery, and public policy.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2009-02       Impact factor: 4.689

Review 2.  The future of direct-to-consumer clinical genetic tests.

Authors:  Felix W Frueh; Henry T Greely; Robert C Green; Stuart Hogarth; Sue Siegel
Journal:  Nat Rev Genet       Date:  2011-06-01       Impact factor: 53.242

3.  Where medicine, business, and public policy intersect.

Authors:  Chantell L Wilson; Stephanie Schultz; Scott A Waldman
Journal:  Biotechnol Healthc       Date:  2007-02

4.  A call for participatory oversight.

Authors:  Sharon F Terry
Journal:  Genet Test Mol Biomarkers       Date:  2014-02

5.  Impact of gene patents and licensing practices on access to genetic testing for long QT syndrome.

Authors:  Misha Angrist; Subhashini Chandrasekharan; Christopher Heaney; Robert Cook-Deegan
Journal:  Genet Med       Date:  2010-04       Impact factor: 8.864

6.  Public reactions to direct-to-consumer genetic health tests: A comparison across the US, UK, Japan and Australia.

Authors:  Jan Charbonneau; Dianne Nicol; Don Chalmers; Kazuto Kato; Natsuko Yamamoto; Jarrod Walshe; Christine Critchley
Journal:  Eur J Hum Genet       Date:  2019-10-23       Impact factor: 5.351
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.